These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32964220)

  • 1. Serotype-specific Cardiac Involvement in Pneumococcal Pneumonia.
    Klugman KP; Feldman C
    Clin Infect Dis; 2022 Feb; 74(3):507-508. PubMed ID: 32964220
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotype Replacement in Adult Pneumococcal Pneumonia after the Introduction of Seven-Valent Pneumococcal Conjugate Vaccines for Children in Japan: a Systematic Literature Review and Pooled Data Analysis.
    Katoh S; Suzuki M; Ariyoshi K; Morimoto K
    Jpn J Infect Dis; 2017 Sep; 70(5):495-501. PubMed ID: 28367876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasopharyngeal carriage of Streptococcus pneumoniae serotypes among children in India prior to the introduction of pneumococcal conjugate vaccines: a cross-sectional study.
    Sutcliffe CG; Shet A; Varghese R; Veeraraghavan B; Manoharan A; Wahl B; Chandy S; Sternal J; Khan R; Singh RK; Santosham M; Arora NK
    BMC Infect Dis; 2019 Jul; 19(1):605. PubMed ID: 31291902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Pneumococcal Conjugate Vaccines Against Community-acquired Alveolar Pneumonia Attributable to Vaccine-serotype Streptococcus pneumoniae Among Children.
    Lewnard JA; Givon-Lavi N; Dagan R
    Clin Infect Dis; 2021 Oct; 73(7):e1423-e1433. PubMed ID: 33346348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotype 1 pneumococcus: epidemiology, genomics, and disease mechanisms.
    Chaguza C; Yang M; Jacques LC; Bentley SD; Kadioglu A
    Trends Microbiol; 2022 Jun; 30(6):581-592. PubMed ID: 34949516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and annual changes in the proportion of Streptococcus pneumoniae serotypes in Japanese adults with pneumococcal pneumonia from 2011 to 2017.
    Noguchi S; Yatera K; Akata K; Chang B; Ikegami H; Hata R; Yamasaki K; Kawanami T; Mukae H
    J Infect Chemother; 2019 Nov; 25(11):925-929. PubMed ID: 31350184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination With the Commensal
    Shekhar S; Åmdal HA; Petersen FC
    Front Immunol; 2021; 12():676488. PubMed ID: 33953733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal Immunization with the Commensal
    Shekhar S; Khan R; Schenck K; Petersen FC
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
    [No Abstract]   [Full Text] [Related]  

  • 9. Necrotizing pneumonia caused by Streptococcus pneumoniae serotype 3 despite PCV13.
    Alkan G; Emiroğlu M; Dağı HT; Gürbüz V; Ceyhan M
    Arch Argent Pediatr; 2019 Apr; 117(2):e155-e157. PubMed ID: 30869496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric cases caused by Streptococcus pneumoniae Serotype 3.
    Ozkaya-Parlakay A; Polat M; Gulhan B; Kanik-Yuksek S; Tezer H; Nar-Otgun S
    Hum Vaccin Immunother; 2019; 15(4):873. PubMed ID: 30582728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands.
    Gessner BD; Jiang Q; Van Werkhoven CH; Sings HL; Webber C; Scott D; Gruber WC; Grobbee DE; Bonten MJM; Jodar L
    Vaccine; 2019 Jul; 37(30):4147-4154. PubMed ID: 31155413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study.
    Lawrence H; Pick H; Baskaran V; Daniel P; Rodrigo C; Ashton D; Edwards-Pritchard RC; Sheppard C; Eletu SD; Litt D; Fry NK; Rose S; Trotter C; McKeever TM; Lim WS
    PLoS Med; 2020 Oct; 17(10):e1003326. PubMed ID: 33095759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive pneumococcal disease caused by mucoid serotype 3 Streptococcus pneumoniae: a case report and literature review.
    Sugimoto N; Yamagishi Y; Hirai J; Sakanashi D; Suematsu H; Nishiyama N; Koizumi Y; Mikamo H
    BMC Res Notes; 2017 Jan; 10(1):21. PubMed ID: 28057059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotype-Switch Variant of Multidrug-Resistant Streptococcus pneumoniae Sequence Type 271.
    Scherer EM; Beall B; Metcalf B
    Emerg Infect Dis; 2021 Jun; 27(6):1689-1692. PubMed ID: 33915076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal conjugate vaccine against serotype 3 pneumococcal pneumonia in adults: A systematic review and pooled analysis.
    McLaughlin JM; Jiang Q; Gessner BD; Swerdlow DL; Sings HL; Isturiz RE; Jodar L
    Vaccine; 2019 Oct; 37(43):6310-6316. PubMed ID: 31522807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN).
    LeBlanc JJ; ElSherif M; Ye L; MacKinnon-Cameron D; Ambrose A; Hatchette TF; Lang ALS; Gillis HD; Martin I; Demczuk W; Andrew MK; Boivin G; Bowie W; Green K; Johnstone J; Loeb M; McCarthy AE; McGeer A; Semret M; Trottier S; Valiquette L; Webster D; McNeil SA
    Vaccine; 2019 Aug; 37(36):5466-5473. PubMed ID: 31345638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel.
    Regev-Yochay G; Chowers M; Chazan B; Gonzalez E; Gray S; Zhang Z; Pride M
    Hum Vaccin Immunother; 2018; 14(10):2527-2532. PubMed ID: 30188760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between serotype-specific antibody response and serotype characteristics in patients with pneumococcal pneumonia, with special reference to degree of encapsulation and invasive potential.
    Athlin S; Kaltoft M; Slotved HC; Herrmann B; Holmberg H; Konradsen HB; Strålin K
    Clin Vaccine Immunol; 2014 Nov; 21(11):1541-9. PubMed ID: 25230937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interim results of an ecological experiment - Conjugate vaccination against the pneumococcus and serotype replacement.
    Hausdorff WP; Hanage WP
    Hum Vaccin Immunother; 2016; 12(2):358-74. PubMed ID: 26905681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent Bacteremia Due to Non-vaccine Serotype 24F Pneumococcus in Twins: A Rapid Increase in Serotype 24F-invasive Pneumococcal Disease and its High Invasive Potential.
    Kawabata T; Tenokuchi Y; Yamakuchi H; Sameshima H; Katayama H; Ota T; Tokunaga M; Takezaki T; Tamae S; Nakamura T; Chang B; Kodama Y; Imuta N; Ooka T; Okamoto Y; Suga S; Nishi J
    Pediatr Infect Dis J; 2020 Jan; 39(1):85-87. PubMed ID: 31815842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.